Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CEOs Want Anti-Kickback, Self-Referral Law Waivers For ACO Interactions

This article was originally published in The Gray Sheet

Executive Summary

The Healthcare Leadership Council – a coalition of health care CEOs – wants Congress to allow more waivers for accountable care organizations from the anti-kickback statute and the Stark law, which protects against physician self-referrals, and are also pushing the same slate of device regulatory reforms as in the House-approved 21st Century Cures bill.

You may also be interested in...



Anti-Kickback Reforms Urged To Support Outcomes-Based System

AdvaMed wants more safe harbors around product warranties and rebates, while the Healthcare Leadership Council is asking for protections for health records software and manufacturer giveaways.

Companies Support Telehealth Reforms – But Seek Demo Projects First

Responding to a chronic care reform effort by the Senate Finance Committee, AdvaMed, device firms and several medical groups asked for demo projects and waivers to appropriately expand the use of telehealth services.

Sen. Murray Prods FDA To Clarify 510(k) Modification Policies In Superbug Bill

Following up on recommendations made in her January report on duodenoscope contamination, Senate HELP Ranking Member Patty Murray, D-Wash., introduced a bill pressing FDA to accelerate its work to clarify when 510(k)s are needed for device modifications and to solidify the agency's authority to deny submissions if the sponsor fails to provide validated reprocessing data.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT034972

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel